{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3702, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de076-55ad-74d3-b9a1-90902cbf53f4", "docSlug": "e307aa667077aaa87591999f61390379", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "team_bio", "function": "other", "notes": "The slide lists 10 advisors with their headshots, names, roles, and company logos.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-55ad-74d3-b9a1-90902cbf53f4/24", "deckHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4", "deckAnchorHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-55ad-74d3-b9a1-90902cbf53f4", "docSlug": "e307aa667077aaa87591999f61390379", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a DNA double-helix motif to represent the company's focus on molecular diagnostics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-55ad-74d3-b9a1-90902cbf53f4/25", "deckHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4", "deckAnchorHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-55ad-74d3-b9a1-90902cbf53f4", "docSlug": "e307aa667077aaa87591999f61390379", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes income statement items, balance sheet data, and equity structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-55ad-74d3-b9a1-90902cbf53f4/26", "deckHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4", "deckAnchorHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-55ad-74d3-b9a1-90902cbf53f4", "docSlug": "e307aa667077aaa87591999f61390379", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-55ad-74d3-b9a1-90902cbf53f4/27", "deckHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4", "deckAnchorHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-55ad-74d3-b9a1-90902cbf53f4", "docSlug": "e307aa667077aaa87591999f61390379", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-55ad-74d3-b9a1-90902cbf53f4/28", "deckHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4", "deckAnchorHref": "/decks/019de076-55ad-74d3-b9a1-90902cbf53f4#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/qQX9QZztvhyxOc4vLHwTipSlBVD0UZrYQvbTXC2nzak/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMDcxNDczZjIzMThiZjI5ZGEyOGRlOTVkZjE3YmE0My9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/1", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/dLMVIMSb6PRRP2-1DcBuJQ8uL5NlqYwQZXGbpUB68xc/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMDcxNDczZjIzMThiZjI5ZGEyOGRlOTVkZjE3YmE0My9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/7LgOt2r_DA0cYgv_Fkfs_N--cl9fukmBTD1w-68QEkc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMDcxNDczZjIzMThiZjI5ZGEyOGRlOTVkZjE3YmE0My9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/gb9_H65hqG8JJhRFJMt8ZD-SQEcYPX4m91LeGxh2DSg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMDcxNDczZjIzMThiZjI5ZGEyOGRlOTVkZjE3YmE0My9wMDAxLnBuZw" }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/2", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "thesis_headline", "function": "present_solution", "notes": "The slide uses a process-flow structure to connect the technology platform (LNCs) to a lead asset (MAT2203) and future pipeline expansion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/3", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "roadmap", "function": "show_traction", "notes": "The slide uses a Gantt-style visualization to show the development stage of various programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/4", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a combination of molecular diagrams and bulleted lists to explain the mechanism and benefits of the LNC technology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/5", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "f7554ad4-4be1-4bca-b387-fb91d33ad3f6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Lipid Nanocrystals (LNCs): A Clinically Validated Intracellular Delivery Platform", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "Technical scientific slide detailing the mechanism of action for a drug delivery platform.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/6", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "f7554ad4-4be1-4bca-b387-fb91d33ad3f6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Lipid Nanocrystals (LNCs): A Clinically Validated Intracellular Delivery Platform", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "comparison_table", "function": "compare_peers", "notes": "The LNC column is highlighted in light yellow to emphasize the company's proprietary technology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/7", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "f7554ad4-4be1-4bca-b387-fb91d33ad3f6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Lipid Nanocrystals (LNCs): A Clinically Validated Intracellular Delivery Platform", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/8", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "f7554ad4-4be1-4bca-b387-fb91d33ad3f6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Lipid Nanocrystals (LNCs): A Clinically Validated Intracellular Delivery Platform", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "why_now", "function": "argue_timing", "notes": "Uses authority-citation to establish urgency and market relevance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/9", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-9", "loopMatches": [ { "to": 16, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092", "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)", "position": 0, "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 9, "beatId": "01f1fbbd-65e1-46cb-a505-f301afa00929", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The growing threat of invasive fungal infections (IFIs)", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "Uses a 'Before-After-Bridge' style logic (Characteristics - Limitations = Unlocked Potential).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/10", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-10", "loopMatches": [ { "to": 16, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092", "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)", "position": 0, "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 10, "from": 10, "beatId": "eb36bd20-6675-4634-9767-d6b9d233cfe8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "MAT2203: Unlocking the Full Potential of Amphotericin B", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a process flow diagram to map clinical outcomes to specific data points.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/11", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-11", "loopMatches": [ { "to": 16, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092", "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)", "position": 0, "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "This is a credibility-building slide showcasing academic validation of the company's technology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/12", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-12", "loopMatches": [ { "to": 16, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092", "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)", "position": 0, "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a human silhouette as a central anchor to map specific clinical indications to anatomical locations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/13", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-13", "loopMatches": [ { "to": 16, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092", "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)", "position": 0, "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "Focuses on patients who failed or could not tolerate standard azole or IV Amphotericin B therapies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/14", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-14", "loopMatches": [ { "to": 16, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092", "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)", "position": 0, "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "other", "function": "illustrate_case", "notes": "The slide uses a timeline diagram combined with two line charts to demonstrate clinical efficacy and safety.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/15", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-15", "loopMatches": [ { "to": 16, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092", "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)", "position": 0, "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "pain_points", "function": "frame_problem", "notes": "The slide highlights both the clinical urgency and the commercial orphan disease opportunity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/16", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-16", "loopMatches": [ { "to": 16, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4e8350fd-f8e5-46e3-b847-1504c590f092", "evidence": "The Growing Threat of Invasive Fungal Infections (IFIs) and High Unmet Medical Need in Treatment of Invasive Aspergillosis (IA)", "position": 0, "objective": "Highlight the high unmet medical need in treatment of invasive aspergillosis (IA)", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "context", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/17", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide uses a process flow diagram to illustrate the clinical trial methodology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/18", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "solution", "function": "present_solution", "notes": "Uses a combination of an equation-style value proposition and a chevron-based process/timeline diagram.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/19", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/20", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a matrix-like structure to map disease areas (Infection, Inflammation, Oncology) to specific animal models and clinical indications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/21", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "traction", "function": "show_traction", "notes": "Data presented as a multi-panel chart comparing Uninfected, Infected Untreated, SQ Remdesivir, and Oral LNC-Remdesivir groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/22", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "traction", "function": "show_traction", "notes": "The chart demonstrates high uptake efficiency of LNC-formulated oligos over time across different cell types.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/23", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "traction", "function": "show_traction", "notes": "The chart shows dose-dependent inhibition; LNC formulations consistently outperform Taxol.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/24", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide demonstrates that oral LNC-docetaxel is as effective as IV docetaxel with no significant side effects.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/25", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "traction", "function": "show_traction", "notes": "The chart shows a clear dose-response relationship with increasing efficacy of the LNC formulation at 2.5, 5, and 10 nM doses.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/26", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "roadmap", "function": "plan_implementation", "notes": "Uses a chevron-based process flow to represent maturity stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/27", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-27", "loopMatches": [ { "to": 29, "from": 27, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "d5dcfd9b-543a-4162-93c1-7a55c50880a6", "evidence": "Rapid Evolution of Platform Sets Stage for Active Q4 and Expanding LNC Intellectual Property Portfolio", "position": 1, "objective": "Explain why now is the right time for Matinas BioPharma", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a grid-based timeline layout to track multiple workstreams simultaneously.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/28", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-28", "loopMatches": [ { "to": 29, "from": 27, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "d5dcfd9b-543a-4162-93c1-7a55c50880a6", "evidence": "Rapid Evolution of Platform Sets Stage for Active Q4 and Expanding LNC Intellectual Property Portfolio", "position": 1, "objective": "Explain why now is the right time for Matinas BioPharma", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "unfair_advantage", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/29", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-29", "loopMatches": [ { "to": 29, "from": 27, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "d5dcfd9b-543a-4162-93c1-7a55c50880a6", "evidence": "Rapid Evolution of Platform Sets Stage for Active Q4 and Expanding LNC Intellectual Property Portfolio", "position": 1, "objective": "Explain why now is the right time for Matinas BioPharma", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/30", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 30, "beatId": "8294223a-e0ec-407c-a9c5-d200792f10f5", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Experienced Leadership Team", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce", "docSlug": "f071473f2318bf29da28de95df17ba43", "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides", "authorId": "matinas-biopharma", "authorName": "Matinas BioPharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "thesis_headline", "function": "summarize", "notes": "The slide uses a mix of checkmarks for completed milestones and circular arrows for pending ones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/31", "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce", "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/BGCJvME6d-qEZpodOWP31scaKHckJPHjVe3RJXSsS8Q/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZGNiNGUxOGY3NzY1NTE5Yzg5Yzg0YzI2YWM5OWFiYS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/1", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/a1ns2BZFa0npHoSVqPGogeqe9uZ3vpjhBszxPEKnEro/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZGNiNGUxOGY3NzY1NTE5Yzg5Yzg0YzI2YWM5OWFiYS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/9dXK4C4pOplxUKTCHOOIm22BvQ25zjiqX1IT5IRMbis/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZGNiNGUxOGY3NzY1NTE5Yzg5Yzg0YzI2YWM5OWFiYS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/dkw1gGyNUkZ-i98vunTN2t-UveC0jbzTE1eU6VEySnM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZGNiNGUxOGY3NzY1NTE5Yzg5Yzg0YzI2YWM5OWFiYS9wMDAxLnBuZw" }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/2", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/3", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-3", "loopMatches": [ { "to": 5, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7287977e-10ad-4572-bd27-16c674890418", "evidence": "The executive summary and key takeaways slides provide an overview of Matson's value proposition", "position": 0, "objective": "Why Matson is a compelling investment opportunity", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 4, "slideType": "geographic_map", "function": "establish_context", "notes": "Includes a detailed inset map for Hawaii and a legend defining service routes and office types.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/4", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-4", "loopMatches": [ { "to": 5, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7287977e-10ad-4572-bd27-16c674890418", "evidence": "The executive summary and key takeaways slides provide an overview of Matson's value proposition", "position": 0, "objective": "Why Matson is a compelling investment opportunity", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "9654f3af-787f-421e-9be4-8a76131919da", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 4 and 5 provide an overview of Matson's geographic presence and investment highlights", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 5, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a table-like layout to pair high-level strategic pillars with specific supporting bullet points.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/5", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-5", "loopMatches": [ { "to": 5, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "7287977e-10ad-4572-bd27-16c674890418", "evidence": "The executive summary and key takeaways slides provide an overview of Matson's value proposition", "position": 0, "objective": "Why Matson is a compelling investment opportunity", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "9654f3af-787f-421e-9be4-8a76131919da", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 4 and 5 provide an overview of Matson's geographic presence and investment highlights", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 6, "slideType": "context", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/6", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "435df159-a2e4-4d62-a8a4-04e2831f10ed", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slide 6 sets the context for Matson's services in Hawaii", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 7, "slideType": "solution", "function": "present_solution", "notes": "Includes a map of the Port of Long Beach showing terminal locations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/7", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 7, "beatId": "02a239f2-64f1-4e57-9106-3dc566f77103", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 7 and 8 present Matson's solution and unfair advantage", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 8, "slideType": "unfair_advantage", "function": "present_solution", "notes": "The slide uses a circular diagram to segment the four pillars of the service offering.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/8", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 9, "slideType": "context", "function": "establish_context", "notes": "Includes a map showing shipping routes between Tacoma and Alaskan ports.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/9", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 10, "slideType": "competitive_analysis", "function": "compare_peers", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/10", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 11, "slideType": "other", "function": "analyze_data", "notes": "The chart shows equity income from 2018 to 2022, with a small LTM 3Q23 bar.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/11", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 12, "slideType": "business_model", "function": "summarize", "notes": "The slide combines a service portfolio description with a dual-axis combo chart showing financial performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/12", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 12, "beatId": "08adbbf3-9290-4b24-bf99-4d1b38e856a3", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Business Model", "beatSlug": "sequoia-pitch-business-model", "evidence": "Slide 12 explains Matson's business model", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 13, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/13", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5711-7736-8edf-56de133eef1b", "docSlug": "3dcb4e18f7765519c89c84c26ac99aba", "documentTitle": "Matson | Investor Presentation Deck | 14 slides", "authorId": "matson", "authorName": "Matson", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 14, "slideType": "appendix_disclosure", "function": "appendix", "notes": "Includes detailed footnotes explaining adjustments for tax benefits/expenses and calculation methodologies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-5711-7736-8edf-56de133eef1b/14", "deckHref": "/decks/019de076-5711-7736-8edf-56de133eef1b", "deckAnchorHref": "/decks/019de076-5711-7736-8edf-56de133eef1b#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-57a4-77f9-94ab-9b0feede6704", "docSlug": "a14e4b0042ed971c9f1fd15d53e19956", "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides", "authorId": "maxcyte", "authorName": "MaxCyte", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/26zXfEM3wUFCw_0O_v2-wWaYYhpnKcRbHaxzLhPZxUc/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMTRlNGIwMDQyZWQ5NzFjOWYxZmQxNWQ1M2UxOTk1Ni9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/1", "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704", "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/rojvPLXBnEYqE8RAyrak2rbib-guDvX4faQjAnTZTj0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMTRlNGIwMDQyZWQ5NzFjOWYxZmQxNWQ1M2UxOTk1Ni9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/aTnpFGHW1M-rHL3UVsJf0B3eulBKc5iQ7Q_HJBLNSSc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMTRlNGIwMDQyZWQ5NzFjOWYxZmQxNWQ1M2UxOTk1Ni9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/k7b_a7q__h5WHaHb5f8OukmIxkg2VCd2WbqUgN9Vmbg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hMTRlNGIwMDQyZWQ5NzFjOWYxZmQxNWQ1M2UxOTk1Ni9wMDAxLnBuZw" }, { "docId": "019de076-57a4-77f9-94ab-9b0feede6704", "docSlug": "a14e4b0042ed971c9f1fd15d53e19956", "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides", "authorId": "maxcyte", "authorName": "MaxCyte", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/2", "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704", "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-57a4-77f9-94ab-9b0feede6704", "docSlug": "a14e4b0042ed971c9f1fd15d53e19956", "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides", "authorId": "maxcyte", "authorName": "MaxCyte", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a three-column layout to summarize key company pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/3", "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704", "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "52a7bca7-5126-4329-babd-d8c1628dbbfe", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 3-5 introduce MaxCyte and the industry challenges", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-57a4-77f9-94ab-9b0feede6704", "docSlug": "a14e4b0042ed971c9f1fd15d53e19956", "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides", "authorId": "maxcyte", "authorName": "MaxCyte", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "timeline", "function": "summarize", "notes": "The slide uses a timeline framework to establish company history and credibility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/4", "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704", "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "52a7bca7-5126-4329-babd-d8c1628dbbfe", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 3-5 introduce MaxCyte and the industry challenges", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-57a4-77f9-94ab-9b0feede6704", "docSlug": "a14e4b0042ed971c9f1fd15d53e19956", "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides", "authorId": "maxcyte", "authorName": "MaxCyte", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "before_after", "function": "diagnose_problem", "notes": "Uses a before-after framing to position the platform as a solution to industry-wide pain points.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/5", "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704", "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-5", "loopMatches": [ { "to": 8, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "bd05f8b9-dd76-46e4-81a1-1bcb8b9816d9", "evidence": "Slides 5-8 imply the consequences of not using MaxCyte's technology", "position": 0, "objective": "Highlight the cost of not addressing industry challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "52a7bca7-5126-4329-babd-d8c1628dbbfe", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 3-5 introduce MaxCyte and the industry challenges", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-57a4-77f9-94ab-9b0feede6704", "docSlug": "a14e4b0042ed971c9f1fd15d53e19956", "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides", "authorId": "maxcyte", "authorName": "MaxCyte", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "kpi_overview", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/6", "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704", "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-6", "loopMatches": [ { "to": 8, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "bd05f8b9-dd76-46e4-81a1-1bcb8b9816d9", "evidence": "Slides 5-8 imply the consequences of not using MaxCyte's technology", "position": 0, "objective": "Highlight the cost of not addressing industry challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "a8e9ed8e-5423-4b14-a02d-57b5166ec8fd", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 6-8 present MaxCyte's ExPERT platform and partnerships", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-57a4-77f9-94ab-9b0feede6704", "docSlug": "a14e4b0042ed971c9f1fd15d53e19956", "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides", "authorId": "maxcyte", "authorName": "MaxCyte", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "other", "function": "present_framework", "notes": "The central hub is 'Accelerate Product Development', surrounded by four key pillars: Shared Momentum, Clinically-Validated Platform, Unparalleled Support, and Streamlined Regulatory Process.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/7", "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704", "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-7", "loopMatches": [ { "to": 8, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "bd05f8b9-dd76-46e4-81a1-1bcb8b9816d9", "evidence": "Slides 5-8 imply the consequences of not using MaxCyte's technology", "position": 0, "objective": "Highlight the cost of not addressing industry challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "a8e9ed8e-5423-4b14-a02d-57b5166ec8fd", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 6-8 present MaxCyte's ExPERT platform and partnerships", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-57a4-77f9-94ab-9b0feede6704", "docSlug": "a14e4b0042ed971c9f1fd15d53e19956", "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides", "authorId": "maxcyte", "authorName": "MaxCyte", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a process flow diagram to show the funnel of partnerships and clinical programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/8", "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704", "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-8", "loopMatches": [ { "to": 8, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "bd05f8b9-dd76-46e4-81a1-1bcb8b9816d9", "evidence": "Slides 5-8 imply the consequences of not using MaxCyte's technology", "position": 0, "objective": "Highlight the cost of not addressing industry challenges", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "a8e9ed8e-5423-4b14-a02d-57b5166ec8fd", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 6-8 present MaxCyte's ExPERT platform and partnerships", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-57a4-77f9-94ab-9b0feede6704", "docSlug": "a14e4b0042ed971c9f1fd15d53e19956", "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides", "authorId": "maxcyte", "authorName": "MaxCyte", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "valuation_reveal", "function": "size_opportunity", "notes": "The chart shows a cumulative growth curve of partner logos over time (2017-2023).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/9", "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704", "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-9", "loopMatches": [ { "to": 12, "from": 9, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "95f03eb0-9033-4b1b-a24a-ab6d09f47a8d", "evidence": "Slides 9-12 discuss revenue upside and partnerships", "position": 1, "objective": "Showcase revenue potential", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "df1ea0f5-4795-4962-88b6-1dc947bcf2f8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 9-12 discuss revenue potential and partnerships", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-57a4-77f9-94ab-9b0feede6704", "docSlug": "a14e4b0042ed971c9f1fd15d53e19956", "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides", "authorId": "maxcyte", "authorName": "MaxCyte", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "revenue_buildup", "function": "quantify_opportunity", "notes": "The chart uses a stacked area format to show the composition of revenue (instruments, milestones, sales-based payments) over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/10", "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704", "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-10", "loopMatches": [ { "to": 12, "from": 9, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "95f03eb0-9033-4b1b-a24a-ab6d09f47a8d", "evidence": "Slides 9-12 discuss revenue upside and partnerships", "position": 1, "objective": "Showcase revenue potential", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "df1ea0f5-4795-4962-88b6-1dc947bcf2f8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 9-12 discuss revenue potential and partnerships", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }